These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1504038)

  • 21. A novel method for the modelling of peptide ligands to their receptors.
    Singh J; Saldanha J; Thornton JM
    Protein Eng; 1991 Feb; 4(3):251-61. PubMed ID: 1857711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Halogen bonding in ligand-receptor systems in the framework of classical force fields.
    Rendine S; Pieraccini S; Forni A; Sironi M
    Phys Chem Chem Phys; 2011 Nov; 13(43):19508-16. PubMed ID: 21964576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes.
    Kim H; Lipscomb WN
    Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxypeptidase A: native, zinc-removed and mercury-replaced forms.
    Greenblatt HM; Feinberg H; Tucker PA; Shoham G
    Acta Crystallogr D Biol Crystallogr; 1998 May; 54(Pt 3):289-305. PubMed ID: 9867434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of carboxypeptidase Y may be altered by changing the hydrophobicity of the S'1 binding pocket.
    Sørensen SB; Breddam K
    Protein Sci; 1997 Oct; 6(10):2227-32. PubMed ID: 9336845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of enzyme-bound ligand dynamics by solid-state NMR in the presence of ligand exchange: L-phenylalanine on carboxypeptidase A.
    Zhang H; Bryant RG
    Biophys J; 1995 Jan; 68(1):303-11. PubMed ID: 7711255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational energies of substrates and inhibitors for carboxypeptidase A: stereoelectronic effect.
    Park JK; Cho SJ; Lee S; Kim KS; Kim DH
    J Biomol Struct Dyn; 1995 Apr; 12(5):1033-40. PubMed ID: 7626238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-Phe complexes of zinc and cobalt carboxypeptidase A.
    Larsen KS; Zhang K; Auld DS
    J Inorg Biochem; 1996 Nov; 64(3):149-62. PubMed ID: 8893517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three high-resolution crystal structures of cadmium-substituted carboxypeptidase A provide insight into the enzymatic function.
    Jensen F; Bukrinsky T; Bjerrum J; Larsen S
    J Biol Inorg Chem; 2002 Apr; 7(4-5):490-9. PubMed ID: 11941507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refined structure of bovine carboxypeptidase A at 1.25 A resolution.
    Kilshtain-Vardi A; Glick M; Greenblatt HM; Goldblum A; Shoham G
    Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):323-33. PubMed ID: 12554943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
    Lee KJ; Kim DH
    Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thioamide substrate of carboxypeptidase A.
    Bartlett PA; Spear KL; Jacobsen NE
    Biochemistry; 1982 Mar; 21(7):1608-11. PubMed ID: 7082637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 A - inhibitor-induced conformational changes.
    van Aalten DM; Chong CR; Joshua-Tor L
    Biochemistry; 2000 Aug; 39(33):10082-9. PubMed ID: 10955996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallographic studies on apocarboxypeptidase A and the complex with glycyl-L-tyrosine.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7151-4. PubMed ID: 6580631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and dynamics of the metal site of cadmium-substituted carboxypeptidase A in solution and crystalline states and under steady-state peptide hydrolysis.
    Bauer R; Danielsen E; Hemmingsen L; Sorensen MV; Ulstrup J; Friis EP; Auld DS; Bjerrum MJ
    Biochemistry; 1997 Sep; 36(38):11514-24. PubMed ID: 9298972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rediscovery of halogen bonds in protein-ligand complexes.
    Zhou P; Tian F; Zou J; Shang Z
    Mini Rev Med Chem; 2010 Apr; 10(4):309-14. PubMed ID: 20470246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positional effects of monofluorinated phenylalanines on histone acetyltransferase stability and activity.
    Voloshchuk N; Zhu AY; Snydacker D; Montclare JK
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5449-51. PubMed ID: 19666222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametrization of halogen bonds in the CHARMM general force field: Improved treatment of ligand-protein interactions.
    Soteras Gutiérrez I; Lin FY; Vanommeslaeghe K; Lemkul JA; Armacost KA; Brooks CL; MacKerell AD
    Bioorg Med Chem; 2016 Oct; 24(20):4812-4825. PubMed ID: 27353885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence and 19F NMR evidence that phenylalanine, 3-L-fluorophenylalanine and 4-L-fluorophenylalanine bind to the L-leucine specific receptor of Escherichia coli.
    Luck LA; Johnson C
    Protein Sci; 2000 Dec; 9(12):2573-6. PubMed ID: 11206079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc environment and cis peptide bonds in carboxypeptidase A at 1.75-A resolution.
    Rees DC; Lewis M; Honzatko RB; Lipscomb WN; Hardman KD
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3408-12. PubMed ID: 6943549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.